CELLINK is awarded Entrepreneur of the Year in Sweden 2019

Last Friday, CELLINK and its four co-founders were awarded the prestigious award, Entrepreneur of the Year in Sweden, 2019.

Each year, the trade organization Företagarna chooses a winner in the award ceremony "Entrepreneur of the Year". The criteria to win the award are, among other things, to show creativity and innovation, to be leaders and role models, and to show profitability and growth. CELLINK has expanded dramatically during the four years since its inception, and today the company has 170 employees at offices in Gothenburg, Kyoto, Stuttgart and Boston.

The award was presented during a gala evening at Stockholm City Hall together with 600 guests, and was received by CELLINK's cofounders Erik Gatenholm, Hector Martinez, Jockum Svanberg and Gusten Danielsson.

The jury's motivation read:

“This year's winner is a pure role model that has gone beyond what is possible. An innovation company responsible for both hardware and consumables to reconstruct what was previously only possible to request from higher powers. These entrepreneurs leave the jury speechless - and we're sure this is just the beginning for the company that prints body parts! Not even the sky is the limit for this year's winner and Entrepreneur of the Year in Sweden 2019: Erik Gatenholm, Hector Martinez, Jockum Svanberg and Gusten Danielsson - CELLINK!”  

For more information, please contact:

Erik Gatenholm, CEO                                                              Gusten Danielsson, CFO
Phone: EU +46 73 267 00 00                                                  Phone: +46 70 991 86 04
US +1 (650) 515 5566                                                             US +1 (857) 332 2138

Email: [email protected]                                                            Email:[email protected]



CELLINK is the leading 3D bioprinter provider and the first bioink company in the world. We focus on developing and commercializing bioprinting technologies to allow researchers to print human organs and tissues for pharmaceutical and cosmetic applications. Founded in 2016 and active in more than 50 countries, CELLINK is changing the future of medicine as we know it. Visit www.cellink.com to learn more. CELLINK is listed on Nasdaq First North Growth Market under CLNK. Erik Penser Bank AB is the company’s certified adviser, available by phone at +46 846 383 00 and by email at: [email protected].

Latest press releases
March 22, 2020RegulatoryUpdate regarding COVID-19
November 14, 2019Annual Report 2018/2019